Biosimilar

Accord BioPharma Launches IMULDOSA®, a Ustekinumab Biosimilar at 92% Discount

Accord BioPharma Launches IMULDOSA®, a Ustekinumab Biosimilar at 92% Discount

19 Aug 2025

1 min read

Lupin, Sandoz Partner to Expand Global Reach of Ranibizumab Biosimilar

Lupin, Sandoz Partner to Expand Global Reach of Ranibizumab Biosimilar

13 Aug 2025

1 min read

Biocon Biologics Receives FDA Approval for Kirsty™, the First and Only Interchangeable Biosimilar to NovoLog® in the U.S.

Biocon Biologics Receives FDA Approval for Kirsty™, the First and Only Interchangeable Biosimilar to NovoLog® in the U.S.

16 Jul 2025

2 min read

Read More

Voice Of HealthCare

vohnetwork.com